Market Overview

Alimera Sciences to Present at the Annual B. Riley Healthcare Conference

Share:

Alimera Sciences to Present at the Annual B. Riley Healthcare Conference

PR Newswire

ATLANTA, Aug. 28, 2018 /PRNewswire/ -- Alimera Sciences (NASDAQ:ALIM), a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that Dan Myers, Chief Executive Officer, will be presenting at the annual B. Riley Healthcare Conference taking place September 4th, 2018 at the Marriott East Side in New York, New York.

(PRNewsfoto/Alimera Sciences, Inc.)

The Company's presentation will take place on Tuesday, September 4th at 10:55AM Eastern Time, a webcast and audio replay will be available for 90 days online at www.alimerasciences.com.

About Alimera Sciences, Inc.
www.alimerasciences.com  
Alimera, founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera's commitment to retina specialists and their patients is manifest in Alimera's product portfolio. For more information, please visit www.alimerasciences.com.

For press inquiries:

For investor inquiries:

Katie Brazel

CG Capital

for Alimera Sciences

for Alimera Sciences

404-317-8361

877-889-1972

kbrazel@bellsouth.net 

investorrelations@cg.capital 

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/alimera-sciences-to-present-at-the-annual-b-riley-healthcare-conference-300702974.html

SOURCE Alimera Sciences, Inc.

View Comments and Join the Discussion!